EC Number | Application | Comment | Organism |
---|---|---|---|
1.2.1.105 | medicine | key regulatory branch points of mitochondrial metabolism are targets of a cellular derivative of phytanic acid, decreased activity of the complexes may contribute to neurological symptoms upon accumulation of phytanic acid in Refsum disease | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.2.1.105 | palmitoyl-CoA | is 10-fold less potent than phytanoyl-CoA, no inhibitory effect up to 0.3 mM | Rattus norvegicus | |
1.2.1.105 | phytanoyl-CoA | is 10-fold more potent than palmitoyl-CoA, no inhibitory effect up to 0.3 mM | Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.2.1.105 | mitochondrion | - |
Rattus norvegicus | 5739 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.2.1.105 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.2.1.105 | by gel filtration | Rattus norvegicus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.2.1.105 | brain | - |
Rattus norvegicus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.2.1.105 | 0.7 | - |
- |
Rattus norvegicus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.2.1.105 | 2-oxoglutarate + [dihydrolipoyllysine-residue succinyltransferase] lipoyllysine | - |
Rattus norvegicus | [dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine + CO2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.2.1.105 | 2-oxoglutarate dehydrogenase | - |
Rattus norvegicus |
1.2.1.105 | 2-oxoglutarate dehydrogenase complex | - |
Rattus norvegicus |
1.2.1.105 | E1o | - |
Rattus norvegicus |